Mostrar el registro sencillo del ítem
dc.contributor.author
Fernández Romero, Lucía
dc.contributor.author
Morello García, Florentina
dc.contributor.author
Laforce, Robert Jr.
dc.contributor.author
Delgado Alonso, Cristina
dc.contributor.author
Delgado Álvarez, Alfonso
dc.contributor.author
Gil Moreno, María José
dc.contributor.author
Lavoie, Monica
dc.contributor.author
Matias Guiu, Jorge
dc.contributor.author
Cuetos, Fernando
dc.contributor.author
Matias Guiu, Jordi
dc.date.available
2025-07-14T15:01:32Z
dc.date.issued
2024-10
dc.identifier.citation
Fernández Romero, Lucía; Morello García, Florentina; Laforce, Robert Jr.; Delgado Alonso, Cristina; Delgado Álvarez, Alfonso; et al.; Comparative accuracy of Mini-Linguistic State Examination, Addenbrooke's Cognitive Examination, and Depistage Cognitif de Quebec for the diagnosis of primary progressive aphasia; IOS Press; Journal of Alzheimer's Disease; 102; 1; 10-2024; 67-76
dc.identifier.issn
1387-2877
dc.identifier.uri
http://hdl.handle.net/11336/265972
dc.description.abstract
Background: Clinical diagnosis in primary progressive aphasia (PPA) is challenging. Recently, emphasis has been placed on the importance of screening evaluation. Three different screening tests that use different strategies based on the assessment of language (Mini-Linguistic State Examination, MLSE) or different cognitive domains (Addenbrooke’s Cognitive Examination, ACE-III and Dépistage Cognitif de Québec, DCQ) have been proposed and independently validated. These tests aim to detect PPA and classify into the three main variants (non-fluent (nfvPPA), semantic (svPPA) and logopenic (lvPPA)). Objective: This study aims to evaluate and compare the diagnostic capacity of these three instruments in PPA. Methods: A cross-sectional study including 43 patients with PPA (nfvPPA (n = 19), svPPA (n = 8), and lvPPA (n = 16)) and 21 cognitively unimpaired controls was conducted. Clinical diagnoses were established based on an extensive multidisciplinary assessment including neuropsychological assessment, fluorodeoxyglucose-positron emission tomography, MRI, and cerebrospinal fluid biomarkers. Both PPA patients and controls completed the three tests (MLSE, ACE-III, and DCQ). Results: Internal consistency was excellent for the three tests. The area under the curve for the diagnosis of PPA was 0.950 for MLSE, 0.953 for ACE-III, and 0.933 for DCQ. Correlations between the three tests were high. The MLSE, ACE-III, and DCQ tests obtained adequate levels of discrimination between the variants of PPA, with accuracies between 76–79%. Conclusions: This study confirms the validity of ACE-III, MLSE, and DCQ for the diagnosis of PPA and its variants. This suggests that detailed assessment of linguistic characteristics (MLSE) and non-linguistic features (DCQ, ACE-III) are relevant for the diagnosis and classification of PPA.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
IOS Press
dc.rights
info:eu-repo/semantics/restrictedAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
ALZHEIMERS DISEASE
dc.subject
FRONTOTEMPORAL DEMENTIA
dc.subject
NEUROPSYCHOLOGICAL ASSESSMENT
dc.subject
PRIMARY PROGRESSIVE APHASIA
dc.subject
SCREENING
dc.subject.classification
Neurociencias
dc.subject.classification
Medicina Básica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.subject.classification
Otras Psicología
dc.subject.classification
Psicología
dc.subject.classification
CIENCIAS SOCIALES
dc.title
Comparative accuracy of Mini-Linguistic State Examination, Addenbrooke's Cognitive Examination, and Depistage Cognitif de Quebec for the diagnosis of primary progressive aphasia
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2025-07-14T11:11:53Z
dc.journal.volume
102
dc.journal.number
1
dc.journal.pagination
67-76
dc.journal.pais
Países Bajos
dc.journal.ciudad
Amsterdam
dc.description.fil
Fil: Fernández Romero, Lucía. Hospital Clínico San Carlos; España
dc.description.fil
Fil: Morello García, Florentina. Universidad de Buenos Aires. Facultad de Psicología; Argentina. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia. Instituto de Neurociencias - Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Neurociencias; Argentina
dc.description.fil
Fil: Laforce, Robert Jr.. Laval University; Canadá
dc.description.fil
Fil: Delgado Alonso, Cristina. Hospital Clínico San Carlos; España
dc.description.fil
Fil: Delgado Álvarez, Alfonso. Hospital Clínico San Carlos; España. Universidad Complutense de Madrid; España
dc.description.fil
Fil: Gil Moreno, María José. Hospital Clínico San Carlos; España
dc.description.fil
Fil: Lavoie, Monica. Laval University; Canadá
dc.description.fil
Fil: Matias Guiu, Jorge. Hospital Clínico San Carlos; España
dc.description.fil
Fil: Cuetos, Fernando. Universidad de Oviedo; España
dc.description.fil
Fil: Matias Guiu, Jordi. Hospital Clínico San Carlos; España
dc.journal.title
Journal of Alzheimer's Disease
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://journals.sagepub.com/doi/10.1177/13872877241284199
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1177/13872877241284199
Archivos asociados